Stay updated on Pemigatinib Dose-Escalation Clinical Trial

Sign up to get notified when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pemigatinib Dose-Escalation Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer site release marker was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a maintenance/site version change rather than study information.
    Difference
    0.0%
    Check dated 2026-04-26T15:42:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-19T14:18:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T21:01:25.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T11:46:00.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Gastric cancer was added to the list of conditions for the study. The page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-12T15:55:22.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 on the page, a minor version update that does not affect study content or navigation. No substantive study information changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:16:07.000Z thumbnail image

Stay in the know with updates to Pemigatinib Dose-Escalation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.